NasdaqGM - Nasdaq Real Time Price USD

Lexeo Therapeutics, Inc. (LXEO)

3.5200
+0.2300
+(6.99%)
As of 2:33:36 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
654
1,657
Operating Expense
116,280
105,766
68,513
61,163
52,294
Operating Income
-116,280
-105,766
-68,513
-60,509
-50,637
Net Non Operating Interest Income Expense
6,981
7,442
2,662
1,234
15
Other Income Expense
-8
-9
-543
-2
-0.1550
Pretax Income
-109,307
-98,333
-66,394
-59,277
-50,622
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-109,307
-98,333
-66,394
-59,277
-50,622
Diluted NI Available to Com Stockholders
-109,307
-98,333
-66,394
-59,277
-50,622
Basic EPS
-3.31
--
-12.40
-2.36
-2.01
Diluted EPS
-3.31
--
-12.40
-2.36
-2.01
Basic Average Shares
33,071.0290
--
5,354.3680
25,169.3280
25,169.3280
Diluted Average Shares
33,071.0290
--
5,354.3680
25,169.3280
25,169.3280
Total Operating Income as Reported
-116,280
-105,766
-68,513
-60,509
-50,637
Total Expenses
116,280
105,766
68,513
61,163
52,294
Net Income from Continuing & Discontinued Operation
-109,307
-98,333
-66,394
-59,277
-50,622
Normalized Income
-109,307
-98,333
-65,864
-59,277
-50,622
Interest Income
7,121
7,579
2,867
1,325
15
Interest Expense
140
137
205
91
0
Net Interest Income
6,981
7,442
2,662
1,234
15
EBIT
-109,167
-98,196
-66,189
-59,186
-50,622
EBITDA
-107,140
-96,194
-64,346
-58,041
-50,609
Reconciled Depreciation
2,027
2,002
1,843
1,145
13
Net Income from Continuing Operation Net Minority Interest
-109,307
-98,333
-66,394
-59,277
-50,622
Total Unusual Items Excluding Goodwill
--
--
-530
--
0
Total Unusual Items
--
--
-530
--
0
Normalized EBITDA
-107,140
-96,194
-63,816
-58,041
-50,609
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/3/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SLDB Solid Biosciences Inc.
2.9100
+0.34%
 
RCKT Rocket Pharmaceuticals, Inc.
6.73
+4.34%
 
SCPH scPharmaceuticals Inc.
3.2450
-7.81%
 
RGNX REGENXBIO Inc.
9.91
+1.17%
 
TECX Tectonic Therapeutic, Inc.
24.02
+2.61%
 
NKTR Nektar Therapeutics
0.6720
-3.31%
 
DSGN Design Therapeutics, Inc.
3.6100
+2.27%
 
FULC Fulcrum Therapeutics, Inc.
6.42
-7.36%
 
RZLT Rezolute, Inc.
3.7950
-0.13%
 
TSHA Taysha Gene Therapies, Inc.
2.9000
+3.94%